3rd Annual Pharma Pricing, Reimbursement & Market Access 2020
“Critical guide for successfully identifying your pricing, reimbursement and market access strategies”
16th & 17th June 2020, Boston, MA USA
This conference will provide an overview of global pricing, market access systems and cost management techniques, as well as in-depth discussion of some of the most current trends and changes. This Conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. It will be studied with the help of case studies and industry experiences.Following a raft of health policy reforms impacting pharmaceutical pricing in almost every major country in the EU.
CONFERENCE SPONSORS:
We have sponsorship opportunities available for the event, which gives you an opportunity to sponsor/speak/exhibit/stall/booth and create brand awareness. In addition, the networking opportunities in focused and relevant industry gathering provide the personal contact necessary for business development efforts.
CONFERENCE DELEGATE PRICING:
Please note that this is a PAID event and NOT A FREE event (no complimentary passes available). Any invite, email or tickets issued mentioning it as a free pass or free ticket to this event through any third party site will strictly not be accepted by the organizer and entry won’t be granted at the event.
Super Early Bird Discount Price:
1 Delegate @ £899 + VAT (Valid Till 31ST March 2020)
3 Delegates @ £1798 + VAT (Valid Till 31ST March 2020)
Early Bird Discount Price:
1 Delegate @ £1099 + VAT (Valid from1st April 2020 - 28th May 2020)
3 Delegates @ £2198 + VAT (Valid from1st April 2020 - 28th May 2020)
Standard Price:
1 Delegate @ £1499 + VAT (Valid from 29th May 2020)
3 Delegates @ £2998 + VAT (Valid from 29th May 2020)
KEY SPEAKERS:
- ROBERT POPOVIAN, Vice President, US Government Relations, Pfizer
- BEHZAD MAHDAVI, VP Strategic Innovation & Alliances, Lonza
- JENNIFER WONG, Senior Director, Real World Evidence, Strategy & Alliances, AstraZeneca
- MARTIN ROST, Senior Director, Market Access (Global), Pfizer
- MATTHEW HURLBURT, Global Access Transformation Lead, Pfizer
- RICHARD LINER, Senior Compliance Counsel, Bayer
- ALEEN HOSDAGHIAN, Sr. Director of Marketing, Sun Pharma
- ALAN POLNARIEV, Medical Science Liaison, Oncology/Urology Gastroenterology, Ferring Pharmaceuticals
- GARY ELLEXSON, VP Corporate Accounts, Supernus Pharmaceuticals
- KELLY PITT, Senior Counsel, Sobi
- JACK JING, Global BD Director / Head of EU Commercial Operations, Seacross Pharmaceuticals
- BOXIONG TANG, Sr. Director, BeiGene
- HEATHER LEIGH FLANNERY, Global Lead, ConsenSys Health
- MICHAEL THOMPSON, President & CEO, National Alliance of Healthcare Purchaser Coalitions
- SHANTHY KRISHNARAJAH, Senior Director, Global Health Economics Reimbursement Strategy, Seqirus
- SUSAN THORNTON, CEO, Cutaneous Lymphoma Foundation
- EVERETT CROSLAND, VP of Market Access & Reimbursement, AppliedVR
- MELVA COVINGTON, Senior Director, EVERSANA, Health Economics and Outcomes Research
- REED STEPHENS, Partner-In-Charge Washington, D.C. Health Industry Advisory Group, McDermott Will & Emery
- SAIRA SULTAN, President & CEO, Connect 4 Strategies
KEY THEMES DISCUSSED:
- Preparing your best market access strategy
- EU and US policy challenges for market access: Stepping ahead
- Unrivalled opportunity to expose and address the market access challenges facing the industry
- Current & future - Challenges & opportunities in pharma pricing, reimbursement & market access
- Improving patient and market access through the development of targeted value propositions, comprehensive contract assessment
- Measurement strategies through to in-depth knowledge regarding payer formulary coverage trends
- How can payers and industry work together to ensure that innovative and valuable treatments make it to the market?
- Understanding - payers’ perspective
- Advocating and collaborating with payers for value in a new era
- Creating a robust patient services and reimbursement support program for biosimilar products
- Prioritising Patients! - Adding value through an innovative patient-centered approach
- Understand how price affects market access and learn on how to set prices for optimal access and returns.
- New drugs are failing to gain reimbursement from payers/HTAs at an alarming rate, despite being approved by regulators
- Evidence Generation - The strategic rigor and creativity applied to evidence generation
- Impact of social media and digital analytics
- Developing risk-sharing reimbursement models and value based pricing
- Patient engagement and adherence within the environment
- Explaining how to use the data sources and observational research for effective safety analysis
- Dwell ahead of regulatory developments & improving your strategies in a cost effective way Accelerating new medicine introduction in developing world & overcoming challenges
- Be part of a major networking opportunity
Get more from the event, with a broader scope bringing the whole communications value chain together. Enjoy and make the best out of our dedicated networking drinks time, meet the leading companies showcasing the products of tomorrow in the co-located exhibition. Expand your knowledge of the latest business models and strategies in the high-level conference.
